Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02118467 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vasoactive Drugs in Intensive Care Unit

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 13, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: May 2014 to May 15, 2014v14
  2. Primary completion date: Dec 2024 to Oct 1, 2026
    • Study completion date: Dec 2025 to Dec 1, 2026
    v13
  3. Primary completion date: Dec 2023 to Dec 2024
    • Study completion date: Dec 2023 to Dec 2025
    v12
  4. Primary and study completion dates: Dec 2021 to Dec 2023v11
  5. Primary completion date: Dec 2020 to Dec 2021v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary completion date: Dec 2019 to Dec 2020
    • Study completion date: Dec 2019 to Dec 2021
    v9
  2. Primary and study completion dates: Dec 2018 to Dec 2019v8
  3. Re-verified, no change to tracked fieldsv7
  4. Primary completion date: Nov 2016 to Dec 2018
    • Study completion date: Jun 2017 to Dec 2018
    v6
  5. Primary completion date: Apr 2016 to Nov 2016v5
  6. Study completion date: Jun 2017v4
  7. Re-verified, no change to tracked fieldsv3
  8. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 2014 to May 2014
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesis is that for ICU patients with shock, the use of the vasoactive drugs phenylephrine and vasopressin will reduce tachydysrhythmias when compared to norepinephrine and epinephrine. To investigate this hypothesis, the investigators are conducting a randomized double blind controlled trial comparing phenylephrine and vasopressin vs. norepinephrine and epinephrine in ICU patients with shock that is not responsive to IV fluids. All patients admitted to the adult intensive care units at the University of Chicago will be screened for eligibility.
Trial Details
NCT Number NCT02118467
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Shock
Related terms Atrial Fibrillation, Diabetes Insipidus, Shock, Tachycardia
Enrollment 836 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov